Fwd: Recommended articles
0 views
Skip to first unread message
Okechukwu Ogah
Jun 10, 2024, 2:23:33 AMJun 10
to nigerian-car...@googlegroups.com
---------- Forwarded message ---------
From: Google Scholar Alerts <scholarale...@google.com>
Date: Sun, 9 Jun 2024, 23:06
Subject: Recommended articles
To: <osoga...@gmail.com>
From: Google Scholar Alerts <scholarale...@google.com>
Date: Sun, 9 Jun 2024, 23:06
Subject: Recommended articles
To: <osoga...@gmail.com>
[HTML] Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction
G Vergaro, A Del Franco, A Carecci, YFF Chen, A Aimo… - International Journal of …, 2024
Background Sacubitril/valsartan has been demonstrated to promote left ventricular
(LV) reverse remodelling and improve outcomes in patients with heart failure (HF)
with reduced ejection fraction (EF). Its molecular and tissue effects have not been …
(LV) reverse remodelling and improve outcomes in patients with heart failure (HF)
with reduced ejection fraction (EF). Its molecular and tissue effects have not been …
 |  |  |  |
See all recommendations
This message was sent by Google Scholar because you're following new recommended articles for your profile.
Okechukwu Ogah
Jun 14, 2024, 1:42:28 PMJun 14
to nigerian-car...@googlegroups.com
Dr O.S Ogah. MBBS, MSc, PhD, MD, FWACP, FACP, FESC, FNCS
A. Senior Lecturer
Cardiology Unit, Department of Medicine,
Faculty of Clinical Sciences
College of Medicine,
University of Ibadan, NIGERIA
B. Honorary Consultant Physician/Cardiologist,
Cardiology Unit,
Department of Medicine
University College Hospital Ibadan, NIGERIA
PERSONAL POSTAL ADDRESS
P.O BOX 14343, UNIVERSITY OF IBADAN POST OFFICE
IBADAN, NIGERIA
C. Bernard Lown Visiting Scholar in Cardiovascular Health
Department of Global Health and Population
Harvard T.H. Chan School of Public Health
Email: oo...@hsph.harvard.edu
D. Adjunct Researcher,
Institute of Advanced Medical Research and Training (IAMRAT)
College of Medicine, University of Ibadan, NIGERIA
E. Affiliate Member,
The Hatter Institute for Cardiovascular Research in Africa (HICRA)
4th Floor Chris Barnard Building
Faculty of Health Sciences
University of Cape Town
Private Bag X3 7935
Observatory, SOUTH AFRICA
Faculty of Health Sciences
University of Cape Town
Private Bag X3 7935
Observatory, SOUTH AFRICA
F. Past President,
Nigerian Cardiac Society
--------------------------------------------------------------------------------------------------------------------------------------------------
"For with thee is the fountain of life: in thy light shall we see light." Psalm 36:9
-------------------------------------------------------------------------------------------------
---------- Forwarded message ---------
From: Google Scholar Alerts <scholarale...@google.com>
Date: Fri, Jun 14, 2024 at 2:49 PM
Subject: Recommended articles
To: <osoga...@gmail.com>
From: Google Scholar Alerts <scholarale...@google.com>
Date: Fri, Jun 14, 2024 at 2:49 PM
Subject: Recommended articles
To: <osoga...@gmail.com>
[HTML] Estimated pulse wave velocity predicts mortality in patients with heart failure with preserved ejection fraction
R Xue, J Zhang, Z Zhen, W Liang, Y Li, L Zhang… - Hellenic Journal of …, 2024
AIM Estimated pulse wave velocity (ePWV), a newly established arterial stiffness
(AS) parameter, predicts development of cardiovascular disease (CVD) and death in
general population or patients with CVD risk factors. However, whether ePWV is …
(AS) parameter, predicts development of cardiovascular disease (CVD) and death in
general population or patients with CVD risk factors. However, whether ePWV is …
| | | |
Comparison of Blood Volume Profiles in Heart Failure With Preserved and Reduced Ejection Fractions: Sex Makes a Difference
WL Miller, DE Grill, BP Mullan - Circulation: Heart Failure, 2024
BACKGROUND: Blood volume (BV) profiles vary markedly in patients with heart
failure (HF), but how HF phenotypes and patient sex impact volume profiles remain
to be explored. The aim of the study was to differentiate BV, plasma volume, and red …
failure (HF), but how HF phenotypes and patient sex impact volume profiles remain
to be explored. The aim of the study was to differentiate BV, plasma volume, and red …
| | | |
Circulating beta‐hydroxybutyrate levels in advanced heart failure with reduced ejection fraction: Determinants and prognostic impact
L Monzo, J Kovar, BA Borlaug, J Benes, M Kotrc… - European Journal of Heart …, 2024
Aims Patients with heart failure (HF) display metabolic alterations, including
heightened ketogenesis, resulting in increased beta‐hydroxybutyrate (β‐OHB)
formation. We aimed to investigate the determinants and prognostic impact of …
heightened ketogenesis, resulting in increased beta‐hydroxybutyrate (β‐OHB)
formation. We aimed to investigate the determinants and prognostic impact of …
| | | |
[HTML] Comparing CHA2DS2-VA and CHA2DS2-VASc scores for stroke risk stratification in patients with atrial fibrillation: a temporal trends analysis from the retrospective …
K Teppo, GYH Lip, KEJ Airaksinen, O Halminen… - The Lancet Regional Health …, 2024
Background Contemporary data have shown a decrease in the ischaemic stroke risk
associated with female sex in patients with atrial fibrillation (AF). We evaluated
temporal trends in the predictive value of a non-sex CHA 2 DS 2-VASc risk score (ie …
associated with female sex in patients with atrial fibrillation (AF). We evaluated
temporal trends in the predictive value of a non-sex CHA 2 DS 2-VASc risk score (ie …
| | | |
Employing Real-World Evidence for the Economic Evaluation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation in Thailand
R Krittayaphong, U Permsuwan - Applied Health Economics and Health Policy, 2024
Background This study aimed to assess the cost-effectiveness of non-vitamin K
antagonist oral anticoagulants (NOACs) in comparison with warfarin using data from
real practice based on the perspective of the health care system in Thailand …
antagonist oral anticoagulants (NOACs) in comparison with warfarin using data from
real practice based on the perspective of the health care system in Thailand …
| | | |
[HTML] Pleiotropic Effects of Direct Oral Anticoagulants in Chronic Heart Failure and Atrial Fibrillation: Machine Learning Analysis
M Mele, A Mele, P Imbrici, F Samarelli, R Purgatorio… - Molecules, 2024
Oral anticoagulant therapy (OAT) for managing atrial fibrillation (AF) encompasses
vitamin K antagonists (VKAs, such as warfarin), which was the mainstay of
anticoagulation therapy before 2010, and direct-acting oral anticoagulants (DOACs …
vitamin K antagonists (VKAs, such as warfarin), which was the mainstay of
anticoagulation therapy before 2010, and direct-acting oral anticoagulants (DOACs …
| | | |
[HTML] Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin
H Norberg, T Andersson, E Håkansson, KH Ängerud… - European Journal of Clinical …, 2024
Objective To assess a systematic implementation approach for introducing
dapagliflozin to individuals with heart failure and reduced ejection fraction in an
outpatient clinical setting. Methods Retrospective medical record data were …
dapagliflozin to individuals with heart failure and reduced ejection fraction in an
outpatient clinical setting. Methods Retrospective medical record data were …
| | | |
[HTML] Sodium-Glucose Cotransporter 2 Inhibitor Improves Neurological Outcomes in Diabetic Patients With Acute Ischemic Stroke
W Yang, JM Kim, M Chung, J Ha, DW Kang, EJ Lee… - Journal of Stroke, 2024
Sodium-Glucose Cotransporter 2 Inhibitor Improves Neurological Outcomes in Diabetic
Patients With Acute Ischemic Stroke - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
Patients With Acute Ischemic Stroke - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main …
| | | |
[PDF] Effect of Sacubitril/Valsartan on Cognitive Function in Patients With Heart Failure With Preserved Ejection Fraction: A Prespecified Analysis of PARAGON-HF
P Dewan, L Shen, J Pedro Ferreira, PS Jhund… - Circulation, 2024
BACKGROUND: A hypothetical concern has been raised that sacubitril/valsartan
might cause cognitive impairment because neprilysin is one of several enzymes
degrading amyloid-β peptides in the brain, some of which are neurotoxic and linked …
might cause cognitive impairment because neprilysin is one of several enzymes
degrading amyloid-β peptides in the brain, some of which are neurotoxic and linked …
| | | |
Peripartum Management of a Patient with Vascular Ehlers-Danlos and Loeys-Dietz Syndromes Complicated by Aortic and Carotid Dissections
MD Jacob Nieb, J Banayan
Peripartum Management of a Patient with Vascular Ehlers-Danlos and Loeys-Dietz
Syndromes Complicated by Aortic and Carotid Disse Page 1 SOAP 2024 ANNUAL
MEETING Peripartum Management of a Patient with Vascular Ehlers-Danlos and …
Syndromes Complicated by Aortic and Carotid Disse Page 1 SOAP 2024 ANNUAL
MEETING Peripartum Management of a Patient with Vascular Ehlers-Danlos and …
Okechukwu Ogah
Jun 22, 2024, 4:18:06 AM (8 days ago) Jun 22
to nigerian-car...@googlegroups.com
Treatment with sacubitril/valsartan effectively manages hypertension and ameliorates left ventricular hypertrophy in hemodialysis patients
N Hu, N Lv, Y Chen - Blood Purification, 2024
Methods Hemodialysis patients with stable blood pressure control were enrolled in
the study. Sacubitril/valsartan was prescribed to replace previously used ACEI/ARB
or other antihypertensive drugs. During a 6-month follow-up period, pre-dialysis …
the study. Sacubitril/valsartan was prescribed to replace previously used ACEI/ARB
or other antihypertensive drugs. During a 6-month follow-up period, pre-dialysis …
| | | |
Patient Focus: Should you take sacubitril/valsartan if you have heart failure with an ejection fraction> 40% and get low blood pressure? An explanation of" Association …
NS Hendren, JT Thibodeau - Journal of cardiac failure, 2024
Patient Focus: Should you take sacubitril/valsartan if you have heart failure with an
ejection fraction >40% and get low blood pressure? An explanation of "Association of
Sacubitril/Valsartan versus Valsartan with Blood Pressure Changes, and Symptomatic …
ejection fraction >40% and get low blood pressure? An explanation of "Association of
Sacubitril/Valsartan versus Valsartan with Blood Pressure Changes, and Symptomatic …
| | | |
[PDF] Balcinrenone plus dapagliflozin in patients with heart failure and chronic kidney disease: Results from the phase 2b MIRACLE trial
CSP Lam, L Køber, K Kuwahara, LH Lund, PB Mark… - European Journal of Heart …, 2024
Aims Many patients with heart failure (HF) have chronic kidney disease (CKD) and
may not tolerate mineralocorticoid receptor antagonists. We investigated the efficacy
and safety of the novel mineralocorticoid receptor modulator balcinrenone in …
may not tolerate mineralocorticoid receptor antagonists. We investigated the efficacy
and safety of the novel mineralocorticoid receptor modulator balcinrenone in …
| | | |
[PDF] The acute effects of furosemide in acute heart failure assessed by remote dielectric sensing. A protocol
NO El Caidi, JD Lukoschewitz, OW Nielsen, J Hove…
ABSTRACT INTRODUCTION. INTRODUCTION. Intravenous loop diuretics have
been a key component in treating pulmonary oedema since the 1960s and have a
Class 1 recommendation in the 2021 guidelines for acute heart failure (AHF). While …
been a key component in treating pulmonary oedema since the 1960s and have a
Class 1 recommendation in the 2021 guidelines for acute heart failure (AHF). While …
Okechukwu Ogah
Jun 22, 2024, 5:02:48 AM (8 days ago) Jun 22
to nigerian-car...@googlegroups.com
Effects of Dapagliflozin on Body Composition and Its Relation to Hemodynamics in Heart Failure With Preserved Ejection Fraction
JA Naser, A Tada, T Harada, YNV Reddy, RE Carter… - Circulation, 2024
Excess adiposity, particularly increases in visceral fat, play a pivotal role in the
pathophysiology of heart failure with preserved ejection fraction (HFpEF). 1
Medicines targeting excess body fat are emerging as effective treatments, including …
pathophysiology of heart failure with preserved ejection fraction (HFpEF). 1
Medicines targeting excess body fat are emerging as effective treatments, including …
| | | |
[HTML] Real-life effectiveness of sacubitril/valsartan in older Belgians with heart failure, reduced ejection fraction and most severe symptoms
E Maury, A Belmans, K Bogaerts, S Vancayzeele… - Scientific Reports, 2024
We assessed the real-world effectiveness of sacubitril/valsartan in patients with
chronic heart failure (HF) and reduced ejection fraction (HFrEF) with an emphasis on
those with older age (≥ 75 years) or with New York Heart Association (NYHA) class …
chronic heart failure (HF) and reduced ejection fraction (HFrEF) with an emphasis on
those with older age (≥ 75 years) or with New York Heart Association (NYHA) class …
| | | |
Change in left atrial function and volume predicts incident heart failure with preserved and reduced ejection fraction: Multi-Ethnic Study of Atherosclerosis
DJ Lim, V Varadarajan, T Quinaglia, T Pezel, C Wu… - European Heart Journal …, 2024
Aims The role of change in left atrial (LA) parameters prior to the onset of heart failure
(HF) remains unclear. We used cardiac magnetic resonance (CMR) imaging to
investigate the relationship between longitudinal change in LA function and incident …
(HF) remains unclear. We used cardiac magnetic resonance (CMR) imaging to
investigate the relationship between longitudinal change in LA function and incident …
| | | |
[HTML] Safety and Efficacy of Dapagliflozin in Patients with Heart Failure with Reduced Ejection Fraction: Multicentre Retrospective Study on Echocardiographic Parameters …
I Battistoni, G Pongetti, E Falchetti, I Giannini, R Olivieri… - Journal of Clinical Medicine, 2024
Objectives: Dapagliflozin has shown efficacy in clinical trials in patients with heart
failure and reduced ejection fraction (HFrEF). However, real-world data on its use
and outcomes in routine clinical practice are limited. We aimed to evaluate the …
failure and reduced ejection fraction (HFrEF). However, real-world data on its use
and outcomes in routine clinical practice are limited. We aimed to evaluate the …
| | | |
[HTML] Liraglutide ameliorates TAC-induced cardiac hypertrophy and heart failure by upregulating expression level of ANP expression
R Li, K Zhang, Z Xu, Y Yu, D Wang, K Li, W Liu, J Pan - Heliyon, 2024
Recent studies have underscored the cardioprotective properties of liraglutide. This
research explores its impact on cardiac hypertrophy and heart failure following
transverse aortic constriction (TAC). We found that liraglutide administration …
research explores its impact on cardiac hypertrophy and heart failure following
transverse aortic constriction (TAC). We found that liraglutide administration …
| | | |
[HTML] A machine learning-derived score to effectively identify heart failure with preserved ejection fraction
KC Bermea, JP Lovell, AG Hays, E Goerlich… - JACC: Advances, 2024
Background The diagnosis of heart failure with preserved ejection fraction (HFpEF)
in the clinical setting remains challenging, especially in obese patients. Objectives
This study aimed to identify novel predictors of HFpEF well suited for obese patients …
in the clinical setting remains challenging, especially in obese patients. Objectives
This study aimed to identify novel predictors of HFpEF well suited for obese patients …
| | | |
[PDF] Epidemiology of Acute Heart Failure in Myocardial Infarction
BM Nazhmidinovna - International Journal of Integrative and Modern …, 2024
Early detection of predictors of acute heart failure (ACF), the fact of myocardial
necrosis, high diagnostic accuracy in the first hours of the disease in patients with
acute coronary syndrome is the most important task of emergency cardiology …
necrosis, high diagnostic accuracy in the first hours of the disease in patients with
acute coronary syndrome is the most important task of emergency cardiology …
Okechukwu Ogah
Jun 22, 2024, 5:14:15 AM (8 days ago) Jun 22
to nigerian-car...@googlegroups.com
Serum bile acid profiles are associated with heart failure with preserved ejection fraction in patients with metabolic dysfunction‐associated fatty liver disease: An …
XD Zhou, CF Xu, QF Chen, MD Shapiro, GYH Lip… - Diabetes, Obesity and Metabolism
Aim To analyse the association between serum bile acid (BA) profile and heart
failure (HF) with preserved ejection fraction (HFpEF) in patients with metabolic
dysfunction‐associated fatty liver disease (MAFLD). Methods We enrolled 163 …
failure (HF) with preserved ejection fraction (HFpEF) in patients with metabolic
dysfunction‐associated fatty liver disease (MAFLD). Methods We enrolled 163 …
| | | |
Outcomes of on-label reduced-dose edoxaban in octogenarian patients with atrial fibrillation
HJ Lee, SH Lee, JW Kim, JY Kim, SJ Park, KM Park… - Europace, 2024
Background Non-vitamin K antagonist oral anticoagulants (NOACs) are effective in
preventing thromboembolisms and reduce the risk of bleeding compared with
warfarin. There are few reports on the outcomes of on-label reduced-dose NOACs …
preventing thromboembolisms and reduce the risk of bleeding compared with
warfarin. There are few reports on the outcomes of on-label reduced-dose NOACs …
| | | |
PCR233 Adherence and Persistence of Oral Anticoagulants for Treatment of Atrial Fibrillation across Stroke and Bleeding Risk Strata
G Ko, E Brouwer, V Dayer, A Katta, S Ramsey, M Lopes… - Value in Health, 2024
Objectives Suboptimal adherence to oral anticoagulants (OACs) to treat atrial
fibrillation (AF) can lead to poor treatment outcomes. This study aimed to evaluate
variations in adherence and persistence to OACs among AF patients across stroke …
fibrillation (AF) can lead to poor treatment outcomes. This study aimed to evaluate
variations in adherence and persistence to OACs among AF patients across stroke …
| | | |
The Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Atrial Electromechanical Conduction Time.
E Çelik, M Kerkütlüoğlu, M Şahin, E Aksu, AS Balcıoğlu - Archives of the Turkish …, 2024
Objective: This study aims to explore the impact of sodium-glucose cotransporter-2
(SGLT-2) inhibitors, a newer class of oral antidiabetic drugs, on atrial
electromechanical delay (EMD) in patients with type 2 diabetes mellitus (DM). This is …
(SGLT-2) inhibitors, a newer class of oral antidiabetic drugs, on atrial
electromechanical delay (EMD) in patients with type 2 diabetes mellitus (DM). This is …
Reply all
Reply to author
Forward
0 new messages